single arm

DRUG9 trials

Sponsors

Pediatric Cardiac Society of India PCSI, Tokyo Metropolitan Children's Medical Center, Martin-Luther-Universität Halle-Wittenberg, Pieter Dewint, MD PhD, Cytosite Biopharma Inc.

Conditions

Advanced Renal Cell CarcinomaComplex Congenital Heart DiseaseCongenital Heart Disease in ChildrenEarly Onset Neonatal SepsisFetal Inflammatory Response SyndromeGlaucomaHealth Condition 1: Q20- Congenital malformations of cardiac chambers and connectionsHealthy

Phase 1

Granzyme B PET Imaging Drug as a Predictor of Immunotherapy Response to Checkpoint Inhibitors

CompletedNCT04169321

Cytosite Biopharma Inc.Lymphoma, Solid Tumor, Unspecified, Adult

Start: 2020-06-16End: 2025-06-09Updated: 2025-08-22

Phase 2

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

RecruitingNCT05767385

University of UtahComplex Congenital Heart Disease, Congenital Heart Disease in Children, Hypoxia +1

Start: 2021-12-17End: 2025-12-31Target: 150Updated: 2025-06-25

Phase 4

Evaluation of the Safety and Effectiveness of Switching From Humira® to Imraldi® in Flanders

CompletedNCT04045782

Pieter Dewint, MD PhDInflammatory Bowel Diseases

Start: 2019-08-19End: 2021-01-29Updated: 2021-04-27

Unknown Phase

Multimodal Monitoring of Fetal Risk of Inflammation in Preterm Premature Rupture of Membranes

CompletedNCT02702297

Martin-Luther-Universität Halle-WittenbergEarly Onset Neonatal Sepsis, Fetal Inflammatory Response Syndrome, Infection of Amniotic Cavity +1

Start: 2016-01-07End: 2018-11-10Updated: 2018-11-14

Prospective Intevention Study of Propylactive and Therapeutic Ethanol-Lock Therapy for the Prevention of Catneter-Related Blood Stream Infection in Pediatric Patients with Home Parenteral Nutrition due to Intestinal Failure

Active, not recruitingJPRN-UMIN000029072

Tokyo Metropolitan Children's Medical CenterPediatric Patients with Home Parenteral Nutrition due to Intestinal Failure

Start: 2017-09-11Target: 10Updated: 2025-07-18

Continued treatment with darunavir/ritonavir in children and adolescents aged 3 years and above with HIV-1

Active, not recruitingRBR-2wjncp

Hospital Geral de Nova IguaçuHuman immunodeficiency virus [HIV] disease

Start: 2010-10-13Updated: 2025-10-27

Assessment of the Impact of an add-on and Its Smartphone Application on the Daily Management of Glaucoma

CompletedNCT04552964

Laboratoires TheaGlaucoma

Start: 2020-09-25End: 2021-04-27Updated: 2021-07-14

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

WithdrawnNCT04941365

Institut du Cancer de Montpellier - Val d'AurelleAdvanced Renal Cell Carcinoma, Healthy, Metastatic Breast Cancer +3

Start: 2022-07-07End: 2024-03-31Updated: 2022-12-22

Study of Breastfeeding practices and Interventions to Help the Same in Babies with Heart Disease After Cardiac Surgery

Active, not recruitingCTRI/2025/03/083204

Pediatric Cardiac Society of India PCSIHealth Condition 1: Q20- Congenital malformations of cardiac chambers and connections

Target: 100Updated: 2025-04-07

Related Papers

Is CONNECTDROP®, a Medication Event Monitoring System Add-On Paired with a Smartphone Application, Acceptable to Patients with Glaucoma for Taking Their Daily Medication? The CONDORE Pilot Study.

2024-04-301 citations

Multimodales Monitoring des fetalen Inflammationsrisikos beim frühen vorzeitigen Blasensprung (MuMfI-PPROM-Trial) Darstellung erster Zwischenergebnisse

Zeitschrift für Geburtshilfe und Neonatologie2017-10-01